Lexaria Bioscience: DehydraTECH Could Transform Oral Delivery In Cannabis, Nicotine, NSAIDs, And Vitamins (seekingalpha.com)

Source: Lexaria Bioscience Investor Presentation Lexaria’s patent on DehydraTECH currently covers the specific use of the technology for cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), and nicotine. Despite the noise on their chart from their volatile trading range, Lexaria Biosciences has been steadily trending up since November 2017 (as can be seen above) and is set to … Continue reading "Lexaria Bioscience: DehydraTECH Could Transform Oral Delivery In Cannabis, Nicotine, NSAIDs, And Vitamins (seekingalpha.com)"

The post Lexaria Bioscience: DehydraTECH Could Transform Oral Delivery In Cannabis, Nicotine, NSAIDs, And Vitamins (seekingalpha.com) appeared first on CBD Oil Reviews And Information | What Is CBD?.

source https://buddicalife.com/lexaria-bioscience-dehydratech-could-transform-oral-delivery-in-cannabis-nicotine-nsaids-and-vitamins-seekingalpha-com/